Novel biomarkers for early detection of gastric cancer

doi:10.3748/wjg.v29.i17.2515

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12327)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

332

WORD

HTML

6013

Figures (1-2)

373

Tables (1-3)

353

Sum=7113

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

4158

Download

267

Sum=4425

Publishing Process of This Article

Item

Count

Browse

201

Download

588

Sum=789

May 7, 2023 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 7, 2023; 29(17): 2515-2533
Published online May 7, 2023. doi: 10.3748/wjg.v29.i17.2515

Full Size Figure Download Figure

Figure 1 Proposed design of circulating tumor DNA-guided treatment strategy in gastric cancer. Schematic presentation of proposed circulating tumor DNA (ctDNA) guided treatment strategy in gastric cancer evaluating tailored treatment based on ctDNA detection. ctDNA positivity was determined by accessing the presence of plasma mutations, which indicates the existence of minimal residual disease. Adapted from Chakrabarti et al[100], and Kasi et al[101]. ctDNA: Circulating tumor DNA; Op: Operative; Adj: Ajuvant chemotherapy.

Citation: Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol 2023; 29(17): 2515-2533
URL: https://www.wjgnet.com/1007-9327/full/v29/i17/2515.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i17.2515